Walla Alelwani
Walla Alelwani publishes mostly in Organic Chemistry, Molecular Biology and Materials Chemistry, on topics such as Synthesis and biological activity, Drug Solubulity and Delivery Systems and Synthesis and Characterization of Heterocyclic Compounds.
- World rank
- #2,490,174 of 7,710,434 ranked researchers
- Rank in Saudi Arabia
- #10,566 of 25,688
- Works
- 58
- Citations
- 892
- Citations per work
- 15.4
What does Walla Alelwani research?
Walla Alelwani's work is mostly in Chemistry (16%), Pharmacology, Toxicology and Pharmaceutics (13%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2949.3%
- Physical Sciences1423.6%
- Chemistry916.0%
- Materials Science47.6%
- Life Sciences1220.8%
- Health Sciences46.3%
- Medicine46.3%
- 1Organic Chemistry16% of their works
- 2Molecular Biology8% of their works
- 3Materials Chemistry8% of their works
- 4Pharmaceutical Science7% of their works
- 5Oncology6% of their works
- 6Pharmacology6% of their works
Research topics
- Synthesis and biological activity
- Drug Solubulity and Delivery Systems
- Synthesis and Characterization of Heterocyclic Compounds
- Computational Drug Discovery Methods
- Nanoparticles: synthesis and applications
- Metal complexes synthesis and properties
- RNA modifications and cancer
- Advancements in Transdermal Drug Delivery
Which keywords describe Walla Alelwani's research?
The keywords of their largest research topics: Anticancer Agents, Medicinal Chemistry, Antimicrobial, Molecular Docking, Heterocyclic Compounds, Tubulin Inhibitors, Cisplatin Resistance and Cyclodextrins.
- m6A-seq
- RNA methylation
- Virtual Screening
- Toxicity
- Solid Dispersions
- Nanoparticles
- Cyclodextrins
- Tubulin Inhibitors
- Molecular Docking
- Medicinal Chemistry
- Anticancer Agents
- Antimicrobial
- Heterocyclic Compounds
- Cisplatin Resistance
- Drug Target Identification
- Platinum-Based Drugs
- Synthesis
- Triazines
- Microneedles
- Solid Lipid Nanoparticles
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Anticancer Agents102 topics
- Medicinal Chemistry102 topics
- Antimicrobial82 topics
- Molecular Docking82 topics
- Heterocyclic Compounds61 topic
- Tubulin Inhibitors61 topic
- Cisplatin Resistance41 topic
- Cyclodextrins41 topic
- Drug Target Identification41 topic
- Nanoparticles41 topic
- Platinum-Based Drugs41 topic
- Solid Dispersions41 topic
- Synthesis41 topic
- Toxicity41 topic
- Triazines41 topic
- Virtual Screening41 topic
- Microneedles31 topic
- RNA methylation31 topic
- Solid Lipid Nanoparticles31 topic
- m6A-seq31 topic
Where does Walla Alelwani work?
Walla Alelwani's main affiliation in the publication record is University of Jeddah, Saudi Arabia.
How many publications and citations does Walla Alelwani have?
OpenAlex counts 58 works and 892 citations for Walla Alelwani, an h-index of 16, ranking #2,490,174 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Walla Alelwani. Posts are plain text and can be reported.